cefclidin

structure given in first source

Also Known As:

3-((4-carbamoyl-1-quinuclidinio)methyl)-7-(2-(5-amino-1,2,4-thiadiazol-3-yl)-2-methoxyiminoacetamido)-8-oxo-5-thia-1-azabicyclo(4,2,0)oct-2-ene-2-carboxylate; E 1040; E-1040; cefaclidine

Networked: 9 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amides: 2428
  - Lactams: 2198
    - beta-Lactams: 2386
      - Cephalosporins: 4007
        cefclidin: 9
- Sulfur Compounds: 278
  - Thiazines: 3
    - Cephalosporins: 4007
      - cefclidin: 9
Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - beta-Lactams: 2386
      - Cephalosporins: 4007
        cefclidin: 9

Related Diseases

1.	Urinary Tract Infections (Urinary Tract Infection) 08/01/1994 - "Efficacy of a novel injectable cephalosporin, Cefclidin, on the experimental complicated urinary tract infections with urinary stones caused by Pseudomonas aeruginosa and Proteus mirabilis." 01/01/1993 - "The therapeutic effect of cefozopran against urinary tract infections caused by Pseudomonas aeruginosa P9 was superior to that of cefpirome and was equal to those of ceftazidime and cefclidin. " 08/01/1994 - "We evaluated the effects of a novel cephalosporin, cefclidin (CFCL) and imipenem (IPM), on the eradication of bacteria from the urine, bladder stones and the kidneys, and also on the prevention of the infection stone formations, in our polymicrobial urinary tract infection model of rats associated with bladder stones using IMP-sensitive or IPM-resistant Pseudomonas aeruginosa and Proteus mirabilis as a causative pathogen. "
2.	Urinary Calculi (Urinary Calculus) 08/01/1994 - "Efficacy of a novel injectable cephalosporin, Cefclidin, on the experimental complicated urinary tract infections with urinary stones caused by Pseudomonas aeruginosa and Proteus mirabilis."
3.	Infections 05/01/1992 - "One hundred thirty-eight patients with severe infections associated with hematopoietic disorders were treated with cefclidin (CFCL), and the efficacy and the safety of the drug were evaluated. " 05/01/1992 - "[Therapeutic effects of cefclidin against severe infections in patients with hematopoietic disorders. " 08/01/1994 - "We evaluated the effects of a novel cephalosporin, cefclidin (CFCL) and imipenem (IPM), on the eradication of bacteria from the urine, bladder stones and the kidneys, and also on the prevention of the infection stone formations, in our polymicrobial urinary tract infection model of rats associated with bladder stones using IMP-sensitive or IPM-resistant Pseudomonas aeruginosa and Proteus mirabilis as a causative pathogen. " 12/01/1992 - "Against Pseudomonas aeruginosa and Acinetobacter calcoaceticus infections, DQ-2556 was more active than cefuzonam and had activity similar to or less than those of ceftazidime, cefpirome, cefepime, and cefclidin. "
4.	Prostatitis 04/01/1992 - "[Clinical study of cefclidin on bacterial prostatitis]." 04/01/1992 - "Cefclidin (CFCL), a new injectable cephem antibiotic, was used in the treatment of bacterial prostatitis. "
5.	Hypersensitivity (Allergy) 09/01/1992 - "Patch testing with cefclidin produced a +/- reaction in 1 of 8 cases, and the drug-induced lymphocyte stimulation test (DLST) elicited a positive response (SI: 2.8) in 1 of 8 and a weakly positive response (1.8 < or = SI < 2) in 2 of 8. From these findings, it seems likely that the eruptions may be partially mediated by delayed type hypersensitivity (DTH) reactions to cefclidin. "

Related Drugs and Biologics

1.	Cephalosporins (Cephalosporin Antibiotics)
2.	Ceftazidime (Fortum)
3.	Cefpirome (HR 810)
4.	Therapeutic Uses
5.	Cefozopran
6.	Fluorescein (Funduscein)
7.	Imipenem
8.	Inosine Monophosphate (IMP)
9.	Anti-Bacterial Agents (Antibiotics)
10.	Cefepime (Maxipime)

Related Therapies and Procedures

1.	Injections
2.	Intravenous Injections